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Angiogenesis involves complex endothelial cell (EC) behav-iors, such as proliferation, survival, migration, and tube for-
mation. The most important stimulus promoting angiogenesis is 
tissue hypoxia. Hypoxia mediates several processes in ECs that 
are required for each step of angiogenesis.1 Hypoxia-induced 
angiogenesis is closely related to pathological situation. The dys-
regulation of these EC behaviors and thus abnormal angiogen-
esis are critically associated with hypoxia-induced pathological 
angiogenesis that occurs during the course of several diseases, 
such as cancer and vascular retinopathy.2,3 Therefore, identifica-
tion of specific molecules involved in hypoxia-induced angio-
genesis will facilitate studies to clarify the various molecular 
mechanisms involved in pathological angiogenesis and may aid 
the discovery of novel angiogenic drug targets.
© 2014 American Heart Association, Inc.
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Objective—Aberrant regulation of the proliferation, survival, and migration of endothelial cells (ECs) is closely related to the 
abnormal angiogenesis that occurs in hypoxia-induced pathological situations, such as cancer and vascular retinopathy. 
Hypoxic conditions and the subsequent upregulation of hypoxia-inducible factor-1α and target genes are important for 
the angiogenic functions of ECs. Phospholipase D2 (PLD2) is a crucial signaling mediator that stimulates the production 
of the second messenger phosphatidic acid. PLD2 is involved in various cellular functions; however, its specific roles in 
ECs under hypoxia and in vivo angiogenesis remain unclear. In the present study, we investigated the potential roles of 
PLD2 in ECs under hypoxia and in hypoxia-induced pathological angiogenesis in vivo.
Approach and Results—Pld2 knockout ECs exhibited decreased hypoxia-induced cellular responses in survival, migration, 
and thus vessel sprouting. Analysis of hypoxia-induced gene expression revealed that PLD2 deficiency disrupted the 
upregulation of hypoxia-inducible factor-1α target genes, including VEGF, PFKFB3, HMOX-1, and NTRK2. Consistent 
with this, PLD2 contributed to hypoxia-induced hypoxia-inducible factor-1α expression at the translational level. The 
roles of PLD2 in hypoxia-induced in vivo pathological angiogenesis were assessed using oxygen-induced retinopathy 
and tumor implantation models in endothelial-specific Pld2 knockout mice. Pld2 endothelial-specific knockout retinae 
showed decreased neovascular tuft formation, despite a larger avascular region. Tumor growth and tumor blood vessel 
formation were also reduced in Pld2 endothelial-specific knockout mice.
Conclusions—Our findings demonstrate a novel role for endothelial PLD2 in the survival and migration of ECs under hypoxia 
via the expression of hypoxia-inducible factor-1α and in pathological retinal angiogenesis and tumor angiogenesis in 
vivo.  (Arterioscler Thromb Vasc Biol. 2014;34:1697-1703.)
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Cellular responses to hypoxic stress are mediated by mul-
tiple mechanisms. Hypoxia-inducible factor-1 (HIF-1) is the 
most prominent factor that mediates cellular responses to 
hypoxia by inducing the expression of several target genes.1 
Because HIF-1 activation is preferentially modulated by 
changes in the amount of the HIF-1α subunit, several fac-
tors and mechanisms have been suggested. Among these, the 
regulation of HIF-1α degradation through post-translational 
modification by oxygen-sensor proteins and subsequent prote-
asomal degradation has been well studied. However, although 
several regulatory mechanisms have been suggested for HIF-
1α synthesis, the exact mechanism is yet to be elucidated.4
Phospholipase D2 (PLD2) is an enzyme that hydrolyzes 
phosphatidylcholine to generate phosphatidic acid and cho-
line.5,6 In response to a variety of upstream stimuli, includ-
ing growth factors and several stress conditions, PLD2 has 
been known to function in a variety of biological phenomena 
by mediating various signaling pathways and cellular func-
tions.5,7–10 However, the pathophysiological roles of PLD2 in 
vivo have only recently been reported.11–13 Furthermore, tis-
sue-specific in vivo functions of PLD2 and its roles in hypoxic 
response have not yet been studied.
In this study, we determined that PLD2 is involved in sur-
vival, migration, and thus sprouting of ECs under hypoxic 
conditions. Our data suggest that PLD2 contributes to hypoxia-
induced expression of HIF-1α through translational regulation 
and hypoxia-induced gene expression, which are important 
for the response of ECs to hypoxic stress. Endothelial-specific 
Pld2 knockout mice (eKO) showed decreased pathological 
angiogenesis in oxygen-induced retinopathy (OIR) and tumor 
implantation models. Our study demonstrated the essential 
role of PLD2 in the cellular processes of ECs under hypoxic 
stress and in pathological angiogenesis in vivo.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results
PLD2 Is Required for Survival, Migration, and 
Sprouting of ECs Under Hypoxic Condition
To study the roles of PLD2 in angiogenesis in vivo, we pro-
duced Pld2 floxed mice with 2 LoxP sequence (Figure IA and 
IB in the online-only Data Supplement). Pld2 floxed mice 
were then crossed with Protamine-Cre transgenic mice for 
whole-body deletion of Pld2, designated knockout (Figure IA 
in the online-only Data Supplement). Deletion of Pld2 was 
confirmed by verifying protein expression using cells isolated 
from mice (Figure IC in the online-only Data Supplement). 
Pld2 knockout mice were viable and fertile and did not exhibit 
detectable phenotypes compared with the wild-type litter-
mates. We then isolated ECs from mice to determine whether 
ablation of Pld2 affects the cellular function of primary ECs.
ECs modulate their cellular processes, including survival, 
proliferation, migration, and tube formation, to generate new 
blood vessels during hypoxic stress.1 To mimic hypoxia-
induced angiogenesis under pathophysiological condition, we 
investigated whether PLD2 plays roles in the cellular func-
tions of isolated mouse lung ECs (MLECs) under hypoxic 
conditions. MLECs from Pld2 knockout mice exhibited 
decreased survival under hypoxic conditions but no signifi-
cant differences under normoxia (Figures 1A and IIA in the 
online-only Data Supplement). Migration was also signifi-
cantly decreased in Pld2 knockout MLECs under hypoxia 
(Figures 1B and IIB in the online-only Data Supplement). 
Decreased survival and migration under hypoxic condition 
were also observed in human primary ECs, human umbilical 
vein ECs, by knockdown of PLD2 (Figure III in the online-
only Data Supplement). We then determined whether PLD2 
contributes to blood vessel growth in an ex vivo angiogen-
esis model. The number of endothelial sprouts and branch-
ing points from explanted aortic rings under hypoxia were 
reduced by PLD2 deficiency (Figure 1C). These data suggest 
that PLD2 is required for EC survival, migration, and vessel 
formation during hypoxic stress.
Hypoxia Response Gene Expression Is 
Decreased in Pld2 Knockout ECs
Cellular responses to hypoxic stress are mediated by multiple 
mechanisms, including regulation of gene expression.1,14 We 




MLEC mouse lung endothelial cell
mTOR mammalian target of rapamycin
OIR oxygen-induced retinopathy
PLD2 phospholipase D2
VEGF vascular endothelial growth factor
Figure 1. Phospholipase D2 (Pld2) deletion reduces survival and 
migration of endothelial cells and endothelial sprouting from aortic 
rings under hypoxic conditions. A, Survival of mouse lung endo-
thelial cells (MLECs) under 1% O2 was measured using an MTT 
(3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) 
assay. B, Confluent MLECs were scratch-wounded and exposed 
to 1% O2. The area of migration was quantified at 12 hours after 
hypoxic exposure (black dotted line: wounded area; white dot-
ted line: leading edge). C, Isolated aortic rings from mice were 
implanted in growth factor–reduced Matrigel and exposed to 1% 
O2 for 5 days. The numbers of endothelial sprouts, branch points, 
and total sprout length were quantified. Scale bar, 100 μm. 
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performed cDNA microarray analysis to assess the gene expres-
sion induced by hypoxia in MLECs (Figure 2A). Differentially 
expressed genes were clustered by hypoxia- and PLD2-
dependent pattern of gene expression, and cluster 3, corre-
sponding to hypoxia-activated and PLD2-dependent suppressed 
genes, included the largest number of differentially expressed 
genes (Figure 2B; Figure IVA and Table I in the online-only 
Data Supplement). Functional classification showed that many 
genes in cluster 3 are involved in angiogenesis and related cel-
lular processes (Figure 2C; Table II in the online-only Data 
Supplement). In the PLD2-dependent clusters (clusters 2−5), 
HIF-1 target genes were most enriched in cluster 3 (Figure 
IVB−IVD in the online-only Data Supplement). Quantitative 
real-time polymerase chain reaction data confirmed that the 
hypoxia-induced expression of vascular endothelial growth 
factor A (Vegf-a), neurotrophic tyrosine kinase receptor type2 
(Ntrk2), 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 
3 (Pfkfb3), and heme oxygenase 1 (Hmox1) were inhibited in 
Pld2 knockout MLECs (Figure 2D). We also verified expres-
sion of several genes for nitric oxide synthases, cell adhesion 
molecules, and oxidative stress that are known to be related to 
angiogenesis. Among these, NADPH (nicotinamide adenine 
dinucleotide phosphate) oxidase 2 (Nox2) was significantly 
decreased by Pld2 knockout (Figure V in the online-only Data 
Supplement).
PLD2 Plays a Positive Role in Translational 
Control of HIF-1α Expression During Hypoxia
An increase in the amount of HIF-1α subunit is the most 
important mechanism for HIF-1 activation and target gene 
expression.15 Therefore, we measured levels of HIF-1α in 
hypoxic MLECs. Consistent with the gene expression data, 
the increased HIF-1α protein levels induced by hypoxia 
were inhibited in Pld2 knockout MLECs (Figure 3A). Time-
dependent expression of HIF-1α under hypoxia was also 
reduced in human umbilical vein ECs after knockdown of 
PLD2 (Figure 3B). Hypoxia-induced HIF-1α expression is 
regulated by synthesis and degradation. To ascertain whether 
PLD2 contributes to HIF-1α synthesis or degradation, we mea-
sured the time-dependent kinetics of hypoxia-induced HIF-1α 
expression after treatment with proteasomal or translation 
Figure 2. Hypoxia-induced gene expression was decreased 
in mouse lung endothelial cells from phospholipase D2 (Pld2) 
knockout (KO) mice. A, Flow chart showing the strategy for gene 
expression analysis and the PLD2-dependent gene selection 
process. B, Differentially expressed genes were clustered by 
hypoxia-responsive and PLD2-dependent genes. Red and green 
colors represent upregulation and downregulation, respectively. 
Colored bars represent the gradient of log2-fold changes (see 
also Figure II in the online-only Data Supplement). W.H and W.N 
refer to hypoxia vs normoxia in wild-type (WT) cells, whereas 
K.H/W.H refers to Pld2 KO vs WT cells under hypoxic condi-
tions. C, Hypoxia-responsive and PLD2-dependent genes in the 
C3 cluster (194 genes) were functionally classified. D, Expres-
sion of PLD2-dependent hypoxia-inducible factor-1α target 
genes was measured by quantitative real-time polymerase chain 
reaction. *P<0.05, **P<0.01. GO indicates gene ontology; H, 
hypoxia; K, knockout; N, normoxia; VEGF, vascular endothelial 
growth factor; and W, wild type.
Figure 3. Phospholipase (PLD) D2 is required for hypoxia (Hyp)-
induced hypoxia-inducible factor-1α (HIF-1α) expression at the 
translational level. The expression of HIF-1α was determined by 
Western blotting. A, Mouse lung endothelial cells were exposed 
to 1% O2 for 5 hours. B, Human umbilical vein endothelial cells 
(HUVECs) were transfected with small interfering RNA and then 
exposed to 1% O2 as indicated. C, Transfected HUVECs were 
treated with 10 nmol/L MG132 to inhibit protein degradation before 
exposure to hypoxia. Cells were harvested at the indicated times 
under 1% O2. D, Transfected HUVECs were incubated under 1% 
O2 for 4 hours, followed by treatment with 10 μg/mL cycloheximide 
(CHX) to inhibit protein translation. Cells were harvested at the indi-
cated times after treatment. Quantitative data in each panel repre-
sent fold change of HIF-1α/actin. *P<0.05. KO indicates knockout; 
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inhibitors (MG132 and cycloheximide, respectively). When 
proteasomal degradation was blocked, hypoxia-induced accu-
mulation of HIF-1α was still reduced by PLD2 knockdown 
(Figure 3C). In contrast, when translation was inhibited, 
silencing PLD2 did not affect HIF-1α levels (Figure 3D). To 
confirm whether PLD2 regulates the transcription of HIF-
1α, we assessed HIF-1α mRNA expression, which was not 
altered by PLD2 knockdown (Figure VI in the online-only 
Data Supplement). These data suggest that PLD2 is positively 
involved in the translational regulation of HIF-1α expression.
Ablation of Pld2 Decreases Retinal 
Angiogenesis and OIR
Retinal hypoxia plays a crucial role in retinal angiogen-
esis through the expression of HIF-1α and VEGF-A.16 To 
assess the roles of PLD2 during in vivo physiological reti-
nal angiogenesis, we measured retinal vascular development 
of wild-type and Pld2 knockout mice at postnatal day 5. 
Radial growth of blood vessels was delayed in retinae from 
Pld2 knockout mice, which showed a decreased number of 
tip cells and proliferative ECs (Figure VII in the online-only 
Data Supplement). However, delayed retinal angiogenesis had 
recovered by postnatal day 14 (data not shown).
Although pathological angiogenesis shares many common 
processes with physiological angiogenesis, in pathological angio-
genesis, formed vessels are not fully functional to resolve oxygen 
demand, and balance of regulatory mechanisms is disrupted.2 
Persistent angiogenesis aggravates the pathological conditions. To 
investigate whether endothelial PLD2 is required for angiogenesis 
under pathological condition, we investigated whether pathologi-
cal angiogenesis occurs during OIR and tumor growth. To focus on 
endothelial functions of PLD2, we generated endothelial-specific 
KO mice, designated Pld2 eKO, by breeding Pld2 floxed mice 
with Tie2-Cre transgenic mice (Figure I in the online-only Data 
Supplement). Pld2 floxed mice were used as the control mice in 
each experiment. Endothelial-specific deletion of PLD2 was con-
firmed by Western blot using isolated ECs and non-ECs from Pld2 
eKO (Figure ID in the online-only Data Supplement). These Pld2 
eKO mice showed normal blood pressure and blood chemistry 
(Table III in the online-only Data Supplement). There were no sig-
nificant changes in vasodilation, vasoconstriction, and vasodilator-
mediated blood pressure lowering (Figure VIII in the online-only 
Data Supplement). In the OIR model, vascular regeneration toward 
the central avascular area was impaired and pathological neovascu-
lar tufts were formed by abnormal proliferation of capillary loops. 
Compared with control mice, Pld2 eKO retinae presented larger 
central avascular areas, suggesting decreased angiogenic activity 
toward the hypoxic avascular area (Figure 4A). Furthermore, Pld2 
eKO mice exhibited less neovascular tuft formation, even in the 
more hypoxic conditions in the larger avascular areas (Figure 4B). 
Therefore, PLD2 is involved in hypoxia-mediated angiogenesis 
during vascular regeneration and pathological angiogenesis.
Tumor Growth and Tumor Angiogenesis 
Are Decreased in Pld2 eKO Mice
Angiogenesis occurs during tumor development, and it is 
essential for tumor growth and metastasis.17 Furthermore, 
aspects of angiogenesis are highly correlated with cancer 
patient prognosis. HIF-1α expression driven by hypoxia, 
which induces the expression of several proangiogenic factors 
such as VEGF, is critical for tumorigenesis. In particular, endo-
thelial expression of HIF-1α and the VEGF autocrine loop are 
essential components of tumor angiogenesis.18 Therefore, we 
studied the roles of PLD2 in tumor angiogenesis. Lewis lung 
carcinoma cells were implanted subcutaneously into the mid-
back region of mice, and tumor growth was measured. Tumor 
growth and weight were significantly decreased in Pld2 eKO 
mice compared with control mice (Figure 5A and 5B). Tumor 
angiogenesis was then assessed by CD31 staining of tumor 
slice. Blood vessel area was decreased in tumors from Pld2 
eKO. The difference between control and eKO was greatest 
in the intratumoral region, which was more hypoxic than the 
tumor periphery (Figure 5C). Furthermore, the hypoxic region 
of tumor sections was larger in Pld2 eKO mice than in con-
trol (Figure 5D). EC proliferation and apoptosis were assessed 
by staining for CD31 with Ki67 or cleaved caspase-3, respec-
tively. Significantly, fewer proliferative ECs (CD31+Ki67+) 
were found in Pld2 eKO tumor sections, whereas the 
Figure 4. Pathological retinal angiogenesis was decreased in an 
oxygen-induced retinopathy (OIR) model in endothelial-specific 
Pld2 knockout (eKO) mice, despite a larger avascular area. 
Retinae from OIR model mice were stained by flat-mount stain-
ing. A, Blood vessels (CD31) and mural cells (SMA and NG2) 
were visualized by fluorescent staining (top). The avascular area 
is denoted by the pink area (bottom) and quantified (right). B, 
Arrows indicate neovascular tuft (NVT) formation (arrow) in the 
retinal quadrant of A (square dotted line), and the NVT area of the 
whole retina was quantified (right). Scale bar, 500 μm. **P<0.01. 
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number of apoptotic ECs (CD31+cleaved caspase-3+) increased 
(Figure 5F). EC barrier functions and vessel leakage are related 
in angiogenesis. In particular, tumor blood vessels are leak-
ier than normal vessels because of continuous remodeling; 
these factors are closely related to tumor prognosis and treat-
ment.17,19 However, vessel leakage was not affected by dele-
tion of endothelial PLD2 (Figure VIIII in the online-only Data 
Supplement). Our data suggest that endothelial PLD2 plays a 
role in pathological angiogenesis during tumor development. 
Furthermore, PLD2 may be essential for survival and prolifera-
tion of ECs in the hypoxic tumor environment.
Discussion
Here, we report that PLD2 is required for the survival and 
migration of ECs, and thus for EC sprouting under hypoxia, by 
regulating the expression of HIF-1α at the levels of translation 
and target gene expression. Endothelial-specific Pld2 deletion 
resulted in decreased vascular regeneration and neovascular 
tuft formation in the OIR model. Furthermore, tumor growth 
in Pld2 eKO mice was reduced with decreased angiogenesis 
in the tumor implantation model. Taken together, these results 
suggest that endothelial expression of PLD2 is required for 
cellular response to hypoxia via HIF-1α–dependent pathway 
and thus is required for angiogenesis in vivo, particularly 
under pathological conditions (Figure 6).
Cellular responses to hypoxic stress are mediated by 
multiple mechanisms, including the activation of the DNA-
binding transcription factor HIF-1.15 Under hypoxic condi-
tions, activated HIF-1 induces the expression of several target 
genes that mediate various adaptive responses to oxygen 
tension, including angiogenesis. Under hypoxic conditions, 
the α-subunit of HIF-1 is synthesized, and its degradation is 
inhibited. Although the post-translational regulation of HIF-
1α, which targets it for degradation after hydroxylation by 
the prolyl hydroxylase-von Hippel–Lindau protein–mediated 
pathway, has been well studied, HIF-1α is also transcribed 
and translated during hypoxia.4 HIF-1α synthesis during 
hypoxia is regulated predominantly at translational level. 
Despite the global reduction of translation during hypoxia,20 
stress response proteins, including HIF-1α, continue to be 
translated. Several mechanisms for the regulation of HIF-1α 
translation, including internal ribosome entry site–dependent 
translation,21 enhanced translation by RNA-binding pro-
teins,22,23 and calcium concentration,4,24 have been suggested 
under different conditions and cell types. In addition, rapamy-
cin, an inhibitor of mammalian target of rapamycin (mTOR), 
is known to inhibit HIF-1α translation, suggesting that mTOR 
contributes to HIF-1α translation under hypoxia, although 
mTOR is inhibited during sustained hypoxia.25–29 However, 
the exact mechanisms that regulate HIF-1α translation are 
unclear. In this study, PLD2 deficiency decreased the expres-
sion of a subset of hypoxia response genes, particularly HIF-
1α target genes. Hypoxia-induced HIF-1α expression was 
reduced in MLECs and human umbilical vein ECs after the 
Figure 5. Tumor growth and angiogenesis were reduced in endo-
thelial-specific Pld2 knockout (eKO) mice. A, Implanted tumor 
volumes were measured every 3 days. B, Tumor weight was 
measured 18 days after implantation. C, Blood vessels in tumor 
slices were stained by CD31, and the vessel area was measured. 
D, Pimonidazole hydrochloride was injected into tumor-bearing 
mice 1 hour before tumor preparation. Hypoxic regions in tumor 
sections were stained with fluorescence. E and F, Proliferative or 
apoptotic vascular endothelial cells in tumor sections were deter-
mined by costaining with CD31 and Ki67 or cleaved caspase-3 
(Casp3), respectively. Scale bar, 100 μm. *P<0.05, **P<0.01.
Figure 6. Roles of phospholipase D2 (PLD2) in pathological 
angiogenesis. Schematic representation of PLD2 functions in 
hypoxia-induced pathological angiogenesis. Under pathologi-
cal conditions, PLD2 in endothelial cells exposed to hypoxia 
upregulates hypoxia-inducible factor-1α (HIF-1α) translation and 
target gene expression. Thus, PLD2 mediates cellular functions, 
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deletion or silencing of PLD2. Furthermore, our data showing 
the effects of MG132 and cycloheximide implicate PLD2 in 
regulating HIF-1α translation. mTOR is an important regu-
lator of protein translation, and regulation of mTOR activity 
by phosphatidic acid has been reported to date.30 Especially, 
PLD2 is required for mTOR activity after direct interaction 
and localized generation of phosphatidic acid.31 Thus, mTOR-
dependent pathway could be one of possible mechanism for 
PLD2-mediated HIF-1α translation. Furthermore, in-depth 
analysis may reveal the details of molecular mechanism of the 
PLD2 contribution in translation of HIF-1α.
HIF-1α is expressed ubiquitously, and its elevated expres-
sion in cancer cells is important for tumor growth and angio-
genesis.32 In addition, endothelial expression of HIF-1α and 
hypoxia-driven VEGF expression are essential for EC behav-
ior, vascular homeostasis, and pathological angiogenesis 
in vivo.18,33 Thus, endothelial knockout of HIF-1α inhibits 
solid tumor growth and angiogenesis.18 Here, we showed that 
PLD2 is required for the survival, proliferation, migration, 
and thus sprouting of ECs under hypoxia. Furthermore, endo-
thelial deletion of Pld2 decreased pathological angiogenesis 
in OIR and tumor models and modulated tip cell formation 
and EC viability. There was also a concurrent reduction in 
the hypoxia-induced expression of Hif-1α, Vegf-A, Pfkfb3, 
Ntrk2, Hmox1, and Nox2. Pfkfb3 is a glycolytic activator that 
regulates proliferation, filopodia/lamellipodia formation, and 
migration in ECs.34 Ntrk2 is an EC survival factor that pro-
motes vessel formation and stabilization.35,36 Hmox-1 protects 
ECs from oxidative stress and regulates placental angiogen-
esis.37 Nox2 is a reactive oxygen species–producing enzyme 
known to be implicated in pathological angiogenesis.38–41 
Collectively, our findings suggest novel roles for endothelial 
PLD2 in regulating hypoxia-induced HIF-1α and downstream 
gene expression, which contribute to the cellular response of 
ECs to hypoxic stress and angiogenesis. This suggests that 
PLD2 is a modulator of EC functions during hypoxic stress 
and angiogenesis under pathological conditions.
Although various roles in different signaling pathways and 
cellular functions have been suggested, the in vivo functions 
of PLD2 have only recently been reported.11–13 In addition, 
although PLD2 is expressed in several cell types, the tissue-
specific functions of PLD2 have not been studied. Therefore, 
studies using tissue-specific knockout mice are required to 
clearly define the in vivo functions of PLD2. Angiogenesis 
occurs as a result of complex processes that occur in vari-
ous cell types.2 We generated endothelial-specific knockout 
mice to assess the endothelial roles of PLD2. Although vessel 
growth was delayed in Pld2 knockout retinae at postnatal day 
5, the delayed retinal angiogenesis was recovered by postnatal 
day 14. Therefore, the effects of PLD2 deficiency may be lim-
ited in physiological angiogenesis, perhaps by compensatory 
mechanisms involving the other isoform, PLD1. However, 
Pld2 eKO mice showed significantly reduced pathological 
angiogenesis in an OIR model. Furthermore, tumor growth 
and angiogenesis were decreased in a tumor implantation 
model. Interestingly, our data are inconsistent with a previous 
study using Pld2 whole-body knockout mice, which reported 
that only PLD1 plays a role in the tumor microenvironment 
during tumor angiogenesis and metastasis.42 Therefore, addi-
tional studies are required to clarify isoform specific– or cell 
type–specific functions of PLDs in angiogenic processes. 
Taken together, our data suggest that the in vivo functions of 
PLD2 could be particularly important in pathological states, 
although it exerts critical roles in general signaling pathways 
and processes. Therefore, PLD2 could be a target for develop-
ment of angiogenic drugs with minimal side effects on physi-
ological angiogenesis. Recently, PLD2-specific inhibitors 
were developed.43 If effective drug for PLD2 is further devel-
oped, specific inhibition of PLD2 could be a potential clini-
cal strategy for several diseases (cancer, diabetic retinopathy, 
and rheumatoid arthritis) closely related with pathological 
angiogenesis.
Acknowledgements
We appreciate the technical assistance of Hoe-Yune Jung with the use 
of the BP-2000 blood pressure analysis system and Nari Kim with the 
use of the Auto Blood Chemistry Analyzer system supported by the 
Pohang Center for Evaluation of Biomaterials (Pohang Technopark).
Sources of funding
This work was supported by grants (NRF-M1AXA002-
2012M3A6A4054249 and No. 2012R1A2A1A03010110) from the 
National Research Foundation, funded by the Korean government 




 1. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the 
HIF system. Nat Med. 2003;9:677–684.
 2. Chung AS, Ferrara N. Developmental and pathological angiogenesis. 
Annu Rev Cell Dev Biol. 2011;27:563–584.
 3. Chung AS, Lee J, Ferrara N. Targeting the tumour vasculature: insights 
from physiological angiogenesis. Nat Rev Cancer. 2010;10:505–514.
 4. Yee Koh M, Spivak-Kroizman TR, Powis G. HIF-1 regulation: not so easy 
come, easy go. Trends Biochem Sci. 2008;33:526–534.
 5. Oude Weernink PA, López de Jesús M, Schmidt M. Phospholipase D sig-
naling: orchestration by PIP2 and small GTPases. Naunyn Schmiedebergs 
Arch Pharmacol. 2007;374:399–411.
 6. Jenkins GM, Frohman MA. Phospholipase D: a lipid centric review. Cell 
Mol Life Sci. 2005;62:2305–2316.
 7. Peng X, Frohman MA. Mammalian phospholipase D physiological and 
pathological roles. Acta Physiol (Oxf). 2012;204:219–226.
 8. Park JB, Lee CS, Jang JH, Ghim J, Kim YJ, You S, Hwang D, Suh PG, 
Ryu SH. Phospholipase signalling networks in cancer. Nat Rev Cancer. 
2012;12:782–792.
 9. Lee CS, Kim KL, Jang JH, Choi YS, Suh PG, Ryu SH. The roles of phospho-
lipase D in EGFR signaling. Biochim Biophys Acta. 2009;1791:862–868.
 10. Jang JH, Lee CS, Hwang D, Ryu SH. Understanding of the roles of phos-
pholipase D and phosphatidic acid through their binding partners. Prog 
Lipid Res. 2012;51:71–81.
 11. Zeng XX, Zheng X, Xiang Y, Cho HP, Jessen JR, Zhong TP, Solnica-
Krezel L, Brown HA. Phospholipase D1 is required for angiogenesis of 
intersegmental blood vessels in zebrafish. Dev Biol. 2009;328:363–376.
 12. Elvers M, Stegner D, Hagedorn I, Kleinschnitz C, Braun A, Kuijpers ME, 
Boesl M, Chen Q, Heemskerk JW, Stoll G, Frohman MA, Nieswandt B. 
Impaired alpha(IIb)beta(3) integrin activation and shear-dependent throm-
bus formation in mice lacking phospholipase D1. Sci Signal. 2010;3:ra1.
 13. Oliveira TG, Chan RB, Tian H, Laredo M, Shui G, Staniszewski A, 
Zhang H, Wang L, Kim TW, Duff KE, Wenk MR, Arancio O, Di Paolo G. 
Phospholipase D2 ablation ameliorates Alzheimer’s disease-linked synap-
tic dysfunction and cognitive deficits. J Neurosci. 2010;30:16419–16428.
 14. Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the 




 http://ahajournals.org by on July 25, 2019
Ghim et al  Roles of PLD2 in Pathological Angiogenesis  1703
 15. Greer SN, Metcalf JL, Wang Y, Ohh M. The updated biology of hypoxia-
inducible factor. EMBO J. 2012;31:2448–2460.
 16. Gariano RF, Gardner TW. Retinal angiogenesis in development and dis-
ease. Nature. 2005;438:960–966.
 17. Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and 
therapeutic targets. Nat Med. 2011;17:1359–1370.
 18. Tang N, Wang L, Esko J, Giordano FJ, Huang Y, Gerber HP, Ferrara N, 
Johnson RS. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-
driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell. 
2004;6:485–495.
 19. Carmeliet P, Jain RK. Principles and mechanisms of vessel normaliza-
tion for cancer and other angiogenic diseases. Nat Rev Drug Discov. 
2011;10:417–427.
 20. Spriggs KA, Bushell M, Willis AE. Translational regulation of gene 
expression during conditions of cell stress. Mol Cell. 2010;40:228–237.
 21. Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1alpha mRNA 
contains an internal ribosome entry site that allows efficient translation 
during normoxia and hypoxia. Mol Biol Cell. 2002;13:1792–1801.
 22. Galbán S, Kuwano Y, Pullmann R, Jr, Martindale JL, Kim HH, Lal A, 
Abdelmohsen K, Yang X, Dang Y, Liu JO, Lewis SM, Holcik M, Gorospe 
M. RNA-binding proteins HuR and PTB promote the translation of 
hypoxia-inducible factor 1alpha. Mol Cell Biol. 2008;28:93–107.
 23. Schepens B, Tinton SA, Bruynooghe Y, Beyaert R, Cornelis S. The polypy-
rimidine tract-binding protein stimulates HIF-1alpha IRES-mediated 
translation during hypoxia. Nucleic Acids Res. 2005;33:6884–6894.
 24. Hui AS, Bauer AL, Striet JB, Schnell PO, Czyzyk-Krzeska MF. Calcium 
signaling stimulates translation of HIF-alpha during hypoxia. FASEB J. 
2006;20:466–475.
 25. Reiling JH, Sabatini DM. Stress and mTORture signaling. Oncogene. 
2006;25:6373–6383.
 26. Koritzinsky M, Magagnin MG, van den Beucken T, Seigneuric R, 
Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken 
JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG. Gene expression 
during acute and prolonged hypoxia is regulated by distinct mechanisms 
of translational control. EMBO J. 2006;25:1114–1125.
 27. Kaper F, Dornhoefer N, Giaccia AJ. Mutations in the PI3K/PTEN/
TSC2 pathway contribute to mammalian target of rapamycin activ-
ity and increased translation under hypoxic conditions. Cancer Res. 
2006;66:1561–1569.
 28. Thomas GV, Tran C, Mellinghoff IK, Welsbie DS, Chan E, Fueger B, 
Czernin J, Sawyers CL. Hypoxia-inducible factor determines sen-
sitivity to inhibitors of mTOR in kidney cancer. Nat Med. 2006;12: 
122–127.
 29. van den Beucken T, Koritzinsky M, Wouters BG. Translational control of 
gene expression during hypoxia. Cancer Biol Ther. 2006;5:749–755.
 30. Foster DA. Regulation of mTOR by phosphatidic acid? Cancer Res. 
2007;67:1–4.
 31. Ha SH, Kim DH, Kim IS, Kim JH, Lee MN, Lee HJ, Kim JH, Jang SK, 
Suh PG, Ryu SH. PLD2 forms a functional complex with mTOR/raptor to 
transduce mitogenic signals. Cell Signal. 2006;18:2283–2291.
 32. Semenza GL. Hypoxia-inducible factors in physiology and medicine. 
Cell. 2012;148:399–408.
 33. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara 
N, Nagy A, Roos KP, Iruela-Arispe ML. Autocrine VEGF signaling is 
required for vascular homeostasis. Cell. 2007;130:691–703.
 34. De Bock K, Georgiadou M, Schoors S, et al. Role of PFKFB3-driven gly-
colysis in vessel sprouting. Cell. 2013;154:651–663.
 35. Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R, Wang 
S, Ibañez CF, Rafii S, Hempstead BL. Brain derived neurotrophic factor 
is an endothelial cell survival factor required for intramyocardial vessel 
stabilization. Development. 2000;127:4531–4540.
 36. Kermani P, Rafii D, Jin DK, Whitlock P, Schaffer W, Chiang A, Vincent L, 
Friedrich M, Shido K, Hackett NR, Crystal RG, Rafii S, Hempstead BL. 
Neurotrophins promote revascularization by local recruitment of TrkB+ 
endothelial cells and systemic mobilization of hematopoietic progenitors. 
J Clin Invest. 2005;115:653–663.
 37. Zhao H, Azuma J, Kalish F, Wong RJ, Stevenson DK. Maternal heme oxy-
genase 1 regulates placental vasculature development via angiogenic fac-
tors in mice. Biol Reprod. 2011;85:1005–1012.
 38. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxi-
dase. Cardiovasc Res. 2006;71:226–235.
 39. Wilkinson-Berka JL, Rana I, Armani R, Agrotis A. Reactive oxygen spe-
cies, Nox and angiotensin II in angiogenesis: implications for retinopathy. 
Clin Sci (Lond). 2013;124:597–615.
 40. Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, 
Alexander RW. Role of gp91phox (Nox2)-containing NAD(P)H oxi-
dase in angiogenesis in response to hindlimb ischemia. Circulation. 
2005;111:2347–2355.
 41. Diebold I, Petry A, Sabrane K, Djordjevic T, Hess J, Görlach A. The HIF1 
target gene NOX2 promotes angiogenesis through urotensin-II. J Cell Sci. 
2012;125(Pt 4):956–964.
 42. Chen Q, Hongu T, Sato T, Zhang Y, Ali W, Cavallo JA, van der Velden A, 
Tian H, Di Paolo G, Nieswandt B, Kanaho Y, Frohman MA. Key roles 
for the lipid signaling enzyme phospholipase d1 in the tumor micro-
environment during tumor angiogenesis and metastasis. Sci Signal. 
2012;5:ra79.
 43. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL, 
Armstrong MD, Arteaga CL, Lindsley CW, Brown HA. Design of iso-
form-selective phospholipase D inhibitors that modulate cancer cell inva-
siveness. Nat Chem Biol. 2009;5:108–117.
Hypoxia-mediated angiogenesis is important under pathophysiological conditions. Under pathological conditions, dysregulated angiogenesis 
is closely related to the progression and prognosis of several diseases including vascular retinopathy and cancer. Therefore, identifying 
specific factors that play roles in pathological angiogenesis is important for developing novel therapeutic strategies. Here, we showed that 
phospholipase D2 (PLD2) contributes to survival and migration of endothelial cells under hypoxic conditions through regulating translation of 
hypoxia-inducible factor-1α and expression of its target genes. Furthermore, we demonstrate roles of endothelial PLD2 in pathological an-
giogenesis with limited effects on physiological angiogenesis, using endothelial-specific Pld2 knockout mice. Our study suggests PLD2 as a 
novel regulator of pathological angiogenesis and provides new mechanistic roles of PLD2 in hypoxic response. In addition, to our knowledge, 
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